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Abstract
Background Mortality rates in perforated peptic ulcer (PPU) have remained unchanged. The aim of this study was to compare
known clinical factors and three scoring systems (American Society of Anesthesiologists (ASA), Boey and peptic ulcer
perforation (PULP)) in the ability to predict mortality in PPU.
Material and Methods This is a consecutive, observational cohort study of patients surgically treated for perforated peptic ulcer
over a decade (January 2001 through December 2010). Primary outcome was 30-day mortality.
Results A total of 172 patients were included, of whom 28 (16 %) died within 30 days. Among the factors associated with
mortality, the PULP score had an odds ratio (OR) of 18.6 and the ASA score had an OR of 11.6, both with an area under the curve
(AUC) of 0.79. The Boey score had an OR of 5.0 and an AUC of 0.75. Hypoalbuminaemia alone (≤37 g/l) achieved an OR of 8.7
and an AUC of 0.78. In multivariable regression, mortality was best predicted by a combination of increasing age, presence of
active cancer and delay from admission to surgery of >24 h, together with hypoalbuminaemia, hyperbilirubinaemia and increased
creatinine values, for a model AUC of 0.89.
Conclusion Six clinical factors predicted 30-daymortality better than available risk scores. Hypoalbuminaemia was the strongest
single predictor of mortality and may be included for improved risk estimation.
Keywords Peptic ulcer perforation . Emergency surgery .
Mortality . Risk score . Outcome analysis
Introduction
While peptic ulcer disease has decreased in incidence over the
past decades, the epidemiological pattern of the complica-
tions, including haemorrhage and perforation, have changed
little.1 Although outcomes from bleeding ulcers have im-
proved with modern endoscopic and interventional radiolog-
ical strategies,2 the outcomes of perforations have remained
fairly unchanged.3 Even in recent reports, the mortality from
perforated peptic ulcer (PPU) remains up to 27 %4–6 and
complications are reported in 20–50 % of the patients.6,7 A
number of scoring systems for outcome prediction have been
reported, yet none appear to be superior and most are inves-
tigated in isolation.8 Among the most frequently used are the
American Society of Anesthesiologists (ASA) physical status
classification system,7 the Boey score9 and the more recently
introduced peptic ulcer perforation (PULP) score.5 However,
only the Boey and PULP scores are designed specifically for
the prediction of mortality for PPU patients. The Boey score is
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the most frequently used score, but with varying degree of
accuracy.7,10,11 The PULP score appears more accurate, yet it
is more complex and has not been validated outside the
original cohort. Consequently, contemporary risk prediction
in PPU patients is less well investigated with no universally
agreed standard, and an optimal way of outcome prediction in
this patient group is not known.
Thus, the aim of this study was to compare known risk
scores and clinical and laboratory factors for the prediction of
30-day mortality in a consecutive cohort of patients surgically
treated for perforated ulcer.
Material and Methods
The study was approved as a quality control assurance project
according to the Regional Ethics Committee (REK Vest #
2011/713). The study was reported to comply with the
Strengthening the Reporting of Observational Studies in Ep-
idemiology (STROBE) statement as best applicable.12
Study Population
The Stavanger University Hospital (SUH) serves as the only
hospital in the greater Stavanger area and has a catchment area
of about 340,000 inhabitants.
All consecutive patients diagnosed with and operated for a
perforated gastric or duodenal ulcer admitted between January
2001 and December 2010 were identified from the hospital
administrative electronic database using ICD-10 diagnostic
codes (K25 and K26) and relevant codes for surgical proce-
dures (i.e. JDA 60 gastroraphy, JDA 61 laparoscopic
gastroraphy, JDH 70 duodenoraphy, JDH 71 laparoscopic
duodenoraphy).
Patient demographics, including laboratory values and
clinical data, were retrieved from hospital records and surgical
notes. Five patients with a malignant ulcer, three patients with
PPU identified at autopsy, seven patients conservatively treat-
ed without operation and two patients operated on suspicion
of PPU without finding any perforation were excluded.
Clinical Diagnosis and Surgical Treatment
Diagnosis was based on clinical symptoms and signs (i.e
presence of peritonitis) supported by imaging (mainly with
abdominal computed tomography (CT)). A standard
predefined set of laboratory values was obtained on admission
for all patients with a suspected ‘acute abdomen’, including,
among others, haemoglobin, C-reactive protein (CRP), liver
enzymes, bilirubin, albumin and creatinine.
The preferred surgical procedure in our institution is an
open or laparoscopic primary closure of the perforation by
interrupted sutures covered with a pedicled omentoplasty.3 In
rare cases with no omentum (or falciform ligament) available,
primary closure without omentoplasty was done.
Study Outcomes
The primary endpoint of the study was mortality defined as
death within 30 days of surgery.
Variables and Definitions
Delay of treatment was measured as time from admittance to
hospital until the start of surgery.
Sepsis was defined as the presence of two or more of the
sepsis criteria (i.e. temperature >38.0, pulse rate >90 beats per
minute, respiration rate >20 per minute) and in addition to
infection being proved or likely.
Shock on admission was defined as a systolic blood pres-
sure of <100 mmHg and a heart rate of >90 beats per minute.
Complications were graded using the Clavien-Dindo
score.13 This classification separates complications into five
categories: grades 1 and 2 are mild complications that can be
medically treated (e.g. pneumonia or urinary tract infections);
grade 3 complications require surgical, endoscopic or radio-
logic intervention; and grade 4 complications are life-
threatening complications. Grade 5 is death of a patient during
the primary hospital stay.
Clinical Risk Scores
The Boey score9 was calculated based upon the presence of
shock, delay from admission to surgery of >24 h and a high
degree of co-morbidity, such as chronic obstructive pulmo-
nary disease, heart failure and active cancer (defined as current
cancer under curative treatment or incurable cancer).
The ASA score14 was based on the patients’ pre-existing
co-morbidity with present clinical condition at admission
taken into consideration. Accordingly, any acute deterioration
of the patient at admission (e.g. fulfilling the sepsis criteria or
the presence of peritonitis or shock) was incorporated in the
ASA score evaluation.
The PULP score5 was based on age of >65 years, co-
morbidity including liver failure, AIDS and active cancer,
concomitant use of steroids, shock on admission, time from
admission to surgery of >24 h, serum creatinine of >130
(μmol/l) and the above-mentioned ASA score.
The Boey score originally measures delay of >24 h from
perforation to surgery, while the PULP score originally mea-
sures time from perforation to admission. Since we measured
time from admission to surgery, this time delay is used for the
calculation of both the Boey score and the PULP score. This
means that a delay of >24 h in this study, represents at least
24 h from perforation to surgery.
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Defining Cut-Offs for Optimal Sensitivity and Specificity
Optimal cut-off for each continuous variable and risk scores
were calculated by the receiver operating characteristics
(ROC) curve analysis with assessment of the area under the
curve (AUC) and its 95% confidence interval (95%CI).15 An
AUC value of >0.8 is considered excellent (i.e. correctly
classifies 80 % of, or four out of five, patients), while an
AUC of 0.70–0.80 is considered acceptable, and a value of
0.5 equals the flip of a coin.16 Sensitivity and specificity with
95 % CI are given for the optimal cut-off value as defined by
the ROC analysis, and in addition, the corresponding positive
or negative likelihood ratio (LR+ or LR−) is given.
Statistical Analysis
Data were analysed using the Statistical Package for Social
Sciences (v. 21, SPSS Inc.). ROC analysis was performed by
MedCalc (v. 12.7.5, http://www.medcalc.org, MedCalc
Software, Ostend, Belgium).
A non-parametric distribution of data was assumed, and
appropriate statistical tests were used for descriptive data. Chi-
square analysis was done for simple associations between
relevant dichotomous values.
Optimal cut-off values (based on ROC analyses) were used
for dichotomization of the variables for use in the binary
regression analyses. Clinical judgement was used for the
cut-off for age, where a clinically defined cut-off was set to
60 years.
Logistic binary regression analysis was performed for mor-
tality as the outcome to identify univariate risk factors. Risk is
presented as odds ratio (OR) with 95 % CI. Factors with a p
value of <0.20 in the univariate analyses were included in the
multivariable logistic regression model, and all multivariable
analyses were adjusted for gender.
The multivariable regression model was built using
the forward conditional mode. Included factors were
tested both for their continuous values and for the
dichotomized variable, where applicable, to test the ro-
bustness of the model. For the final multivariable mod-
el, the corresponding ‘predicted probability’ value given
for each patient was tested by ROC analysis to estimate
the performance of the model by the AUC. In addition,
the same was run for each of the ASA, PULP and Boey
scores in order to compare the accuracy performance
across the models. In addition, the Hosmer and
Lemeshow goodness-of-fit test was performed for the
final multivariable regression model. For internal vali-
dation, boostrapping by 1,000 samples was performed
on the final multivariable regression model. All tests are
two-sided and p values of <0.05 were regarded as
statistically significant.
Results
The study population comprised 172 patients with a median
age of 68 (range 18–101)years. Patient characteristics are
given in Table 1. The 30-day mortality was 16.3 % (28/172),
and complications were encountered in 52 % (89/172) of the
patients (Fig. 1). There were no grade 1 complications record-
ed. Among the complications recorded were ten suture leak-
ages from the ulcer site, five in the laparotomy and five in the
laparoscopy group (p=0.13) Suture leaks were not associated
with mortality (p=0.585).
Optimal cut-off values for each continuous variable based
on ROC are given in Table 2. A large variability in discrim-
ination is shown, and none of the variables scored an AUC
over 0.8. The LR+was consistently low, with none having a
value over 4.
Risk Factors for Mortality
Univariate risk factors associated with mortality are displayed
in Table 3. In addition, we analysed for ulcer site, method of
operation, presence of cardiovascular disease, prednisolone
use, smoking, sepsis, autoimmune disease and NSAID use,
but none were statistically significantly associated with mor-
tality. Absence of peritonitis on admission was significantly
associated with mortality (p=0.038) by univariate analysis,
but not after multivariable regression analysis.
During multivariable modelling, non-significant variables
were taken out of the regression model for optimization.
Adding or leaving the ASA score out of the model only
changed the model minimally, and the ASA score was thus
left out. The final multivariable regression model for mortality
is presented in Table 4. The Hosmer and Lemeshow
goodness-of-fit test (p=0.948) indicated a good model fit,
and ROC analyses of the predicted probability value gave an
AUC of 0.89 (Fig. 2a). The model was internally validated by
bootstrapping, changing the p values only marginally, thus
confirming the validity of the model (see Supplementary info,
Table 5).
The predicted probability of each of the clinical scores, as
well as the predicted probability used for variables included in
the final model (Table 4), is presented for comparison in
Fig. 2a–d. The final model had a better AUC and more
consistent 95 % CI (Fig. 2a), compared to the PULP
(Fig. 2b), Boey (Fig. 2c) and ASA (Fig. 2d) scores.
Discussion
In the current study, several clinical factors were predictive of
30-day post-operative mortality, of which the combination of
increasing age, the presence of active cancer, the state of
hypoalbuminaemia, presence of hyperbilirubinaemia, delay
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to surgery of >24 h and increased creatinine represented the
best predictive model. Indicated by an AUC of 0.89, this
model would correctly classify nine out of ten patients.
Notably, the included factors are all objective measures that
are obtainable before surgery and could thus be used for
improved risk prediction. While all clinical risk scores evalu-
ated had reasonably accurate ability to predict mortality, none
were excellent as deemed by the AUC. Moreover, the single
most important factor, the state of hypoalbuminaemia, is not
included in any of the three existing risk scores.
An improved risk prediction model may be used for better
communication with patients and next-of-kin before surgery
for this disease with known highmortality. Obviously, a single
predictor cannot be attributed to any individual patient, but the
presence of several or all of the most detrimental factors may
pose a much greater mortality risk compared to patients with
few or none of these attributes. Also, for clinical resource
allocation and planning (e.g. risk for prolonged ICU or hos-
pital stay, or need of prolonged care), the combined set of
variables may be useful. Finally, the combined score may
better allow comparison of patients between studies and allow
Fig. 1 Distribution of complications according to the Clavien-Dindo
complication grading systems
Table 1 Clinicopathological characteristics of patients operated for perforated peptic ulcer
Characteristics (N=172) Age <60 years (n=55) Age ≥60 years (n=117) p valuea for difference
Gender, n (%)
Female 20 (36) 69 (59) 0.006
Male 35 (64) 48 (41)
Location of ulcer, n (%)
Duodenal 18 (33) 42 (36) 0.606
Gastric 37 (67) 75 (64)
Delay to surgery (h), median (range) 6.3 (0.5–52.4) 6.2 (1.1–116.2) 0.463
Operation time in min, median (range) 78 (41–210) 79 (34–291) 0.890
Laparoscopy 16 (29) 34 (29) 0.997
Laparotomy 39 (71) 83 (71)
ASA score
1–2 47 (85) 52 (44) <0.001
≥3 8 (15) 65 (56)
Boey score
≤1 47 (85) 69 (59) 0.001
>1 8 (15) 48 (41)
PULP score
<6 48 (87) 38 (32) <0.001b
≥6 7 (13) 79 (68)
Median (range) 3 (1–10) 8 (1–14)
Albumin (g/L)
Median (range) 42 (20–48) 37 (14–48) <0.001
Hypoalbuminaemia (≤37 g/l), n (%) 9 (5) 63 (37) <0.001
Bilirubin (μmol/l)
Median (range) 8 (3–197) 12 (2–481) 0.004
Hyperbilirubinaemia, n (%) 6 (4) 18 (11) 0.418
Creatinine (μmol/l)
Median (range) 78 (27–583) 88 (34–507) 0.124
Creatinine>118 6 (4) 32 (19) 0.015
a p value was calculated by chi-square test for categorical data and Mann-Whitney U test for continuous data
b p value represents differance between PULP scores <6 and ≥6
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for case mix adjustments and, importantly, may also allow for
potential risk stratification for future clinical trails. Compari-
son between different patient cohorts from different regions
may be valid, as all variables are objective and not influenced
by subjective interpretation.
Hypoalbuminaemia was strongly associated with increased
mortality, and this is in line with previous reports on perforat-
ed peptic ulcer.17 Indeed, several past studies found a relation
between preoperative hypoalbuminaemia and poor post-
operative outcomes across several surgical disciplines.18–20
Table 2 Optimal cut-off based on receiver operating characteristics (ROC) curve analysis for 30-day mortality
Factor Cut-off Sensitivity (95 % CI) Specificity (95 % CI) AUC p value of AUC LR+ LR−
Age (years) >79 53.6 (33.9–72.5) 83.3 (76.2–89.0) 0.74 <0.001 3.2 0.6
Delay (h) >14 48.2 (28.7–68.1) 75.5 (67.6–82.3) 0.58 0.22 2.0 0.7
Operation time (min) ≤86 75.0 (55.1–89.3) 41.6 (33.3–50.1) 0.52 0.74 1.3 0.6
ASA score >3 85.7 (67.3–96.0) 66.0 (57.6–73.7) 0.79 <0.001 2.5 0.2
Boey score >1 64.3 (44.1–81.4) 94.4 (89.3–97.6) 0.75 <0.001 2.5 0.5
PULP score >6 92.9 (76.5–99.1) 58.3 (49.8–66.5) 0.79 <0.001 2.3 0.1
Albumin (g/l) ≤37 82.1 (63.1–93.9) 65.5 (57.1–73.3) 0.78 <0.001 2.4 0.3
Bilirubin (μmol/l) >19 35.7 (18.6–55.9) 90.2 (84.1–94.5) 0.61 0.096 3.7 0.7
Creatinine (μmol/l) >118 42.9 (24.5–62.8) 81.9 (74.7–87.9) 0.52 0.78 2.4 0.7
CRP (mg/l) >21 78.6 (59.0–91.7) 52.8 (44.3–61.1) 0.69 <0.001 1.7 0.4
AUC area under the curve, LR+ positive likelihood ratio, LR− negative likelihood ratio, ASA score American Society of Anesthesiologists score, PULP
score peptic ulcer perforation score
Table 3 Univariate regression analysis of factors associated with 30-day mortality
Factors Deceased Alive p value Odds ratio (95 % CI)
Gender Male 11 72 0.299 0.6 (0.3–1.5)
Female 17 72
Age (years) >60 25 92 <0.001 4.7 (1.4–16.4)
≤60 3 52
Delay (h) >24 9 22 0.027 2.8 (1.1–6.9)
≤24 18 121
Preoperative shock Yes 10 27 0.034 2.6 (1.1–6.2)
No 17 117
Active cancer Yes 9 10 <0.001 6.4 (2.3–17.6)
No 19 134
Peritonitis Yes 13 99 0.034 0.4 (0.2–1.0)
No 14 44
ASA score >3 24 49 <0.001 11.6 (3.8–35.4)
≤3 4 95
Boey score >1 18 38 <0.001 5.0 (2.1–11.8)
≤1 10 106
PULP score >6 26 60 <0.001 18.2 (4.2–79.6)
≤6 2 84
Albumin (g/l) >37 5 93 <0.001 8.7 (3.1–24.4)
≤37 23 49
Bilirubin (μmol/l) >19 10 14 <0.001 5.1 (2.0–13.2)
≤19 18 129
Creatinine (μmol/l) >118 12 26 0.004 3.4 (1.4–8.1)
≤118 16 118
CRP (mg/l) >21 22 68 0.002 4.1 (1.6–10.7)
≤21 6 76
Haemoglobin (g/dl) >12.5 14 106 0.013 2.8 (1.2–6.4)
≤12.5 14 38
ASA score American Society of Anesthesiologists score, PULP score peptic ulcer perforation score
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This association may be due to the fact that a low serum
albumin is closely correlated to a poor preoperative status of
the patient, due to chronic disease, presence of underlying
cancer, state of cachexia or other causes of malnutrition.
Hyperbilirubinaemia has been found to be associated with
perforation in acute appendicitis, and this has been partly
explained by a decrease in bile secretion as a consequence of
bacteraemia.21 Since similar mechanisms may apply for a
perforated ulcer, hyperbilirubinaemia may also be of rele-
vance in the management of PPU patients.
Møller et al. found a decrease in mortality from 27 to 17 %
after initiating a care bundle protocol.22 In the current cohort,
the mortality is 16 %, and the two cohorts appear comparable
in most aspects. Also, the mortality in our study is in the range
of 10–27 % as reported by recent studies from a number of
countries, including the USA, Denmark, Scotland, Israel,
Nigeria and Ethiopia.8,23–28 As our study includes ‘all comers’
in a defined population with no selection in referral, we
believe that the mortality rate is as would be expected for this
group of patients.
Most of the deaths in the cohort were attributed to sepsis
and multiorgane failure,6 which corroborates previous find-
ings in PPU.29 However, the presence of sepsis preoperatively
was not found to be significantly associated with mortality in
the current study. Notably, several other factors may likely be
related to the sepsis syndrome and act as surrogates for the
presence of sepsis, such as hyperbilirubinaemia and increased
creatinine. Increased creatinine levels may be an indicator of
several conditions, including chronic renal failure (known or
unknown before diagnosis), the expression of pending renal
failure (due to the current disease), but may also be due to
dehydration or reflect shock or sepsis per se. Nevertheless,
increased creatinine is a well-recognized risk factor for mor-
tality both in PPU patients and in other patient groups.5,20
Indeed, we recognize that several of the factors deemed to be
of importance (e.g. albumin, bilirubin and creatinine levels)
may be surrogates or indicators for other underlying factors,
most likely attributed to pre-existing disease (such as presence
of cancer or severe chronic illness) or the state of the acute
disease (e.g. reflecting dehydration, state of infection or sep-
sis, or altered physiology or pending organ failure).We did not
Table 4 Multivariable regression analysis of factors associated with 30-
day mortality
Factors Wald p value Odds ratio (95 % CI)
Age 10.2 0.001 1.1 (1.0–1.1)
Delay >24 h 4.4 0.035 3.5 (1.1–11.3)
Active cancer 7.8 0.005 7.6 (1.8–31.7)
Albumin ≤37 g/l 5.6 0.018 4.1 (1.3–13.8)
Bilirubin >19 μmol/l 6.5 0.011 5.1 (1.5–18.2)
Creatinine >118 μmol/l 4.4 0.036 3.5 (1.1–11.1)
Adjusted for gender
Fig. 2 ROC analysis of scores
and current model in mortality
prediction: a current model from
the predictive probabilities of the
multivariable regression model, b
the PULP score, c the Boey score
and d the ASA score
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attempt to define or investigate causality from the findings in
this study. Further investigation into the ‘cause and conse-
quence’ interactions for the better understanding of the nature
of this disease is clearly warranted.
Incorporating ‘delay’ as a risk factor is controversial and
inconsistent across studies. The Boey score originally mea-
sures ‘delay’ as the time from perforation to surgery, which
may be prone to error based on recall bias by the patient or
record bias when prehospital data are to be obtained in retro-
spect. On the other side, the PULP score measures ‘delay’ as
the time from perforation to admission, thus not including the
potential diagnostic delay that may occur in some patients
prior to an established diagnosis and start of treatment. In the
current study, we have obtained ‘delay’ as the time interval
from admission to surgery, as we believe this to be a more
robust predictor, as admission to hospital and start of surgery
are consistently recorded. Hence, this was applied as the ‘time
delay’ variable for both the PULP score and the Boey score.
This means that a delay of >24 h (from admission) represents
at least 24 h of delay (since symptom debut). Notably, as our
institution covers a region with fairly short travelling dis-
tances, the time from perforation to admission should not be
considerable for most patients. However, we cannot rule out
an influence of this on the score parameters. Even though the
PULP score achieved both higher OR and AUC values, the
Boey score is a much simpler score with higher clinical
usefulness than the more complex PULP score, ranging from
0 to 18 points.
The ASA score and the PULP score performed equally
well by most aspects in our cohort. The reason for this can to
some extent be attributed to our patients receiving higher ASA
grading. The ASA grading is known to have interobserver
variability, since it is not an objective system.30 The ASA
grade also varies according to whether or not the acute state is
taken into consideration for the ASA grading.31 Most of the
factors in the PULP score are related to preoperative status and
could be included in the ASA score alone, except of age and
prednisolone use. Since we included the acute state when
grading ASA, it is not so surprising that the PULP score and
the ASA score performed equally well. However, the ASA
grading which is only based upon pre-existing illness can also
be problematic. Clearly, a previous healthy patient presenting
with septic shock and acute multiorgane failure is at high risk,
but ignoring this in the ASA grading can be misleading.
The question remains how to best improve outcomes for
the patients at high risk of dismal outcomes. As recently
discussed, there are several important prognostic factors that
are unmodifiable, such as age and the presence of active
cancer.3 However, other important prognostic factors for mor-
tality may be modifiable. As already addressed in the PULP
study, the adherence to a sepsis-focused protocol could reduce
the mortality by one third compared to conventional
treatment,22 but when introducing this as a quality-of-care
initiative, the factors that improvedmost were delay to surgery
and monitoring of vital parameters, with no significant change
in mortality.32 To decrease the time interval from perforation
to operation appears particularly important as each hour of
delay carries with it a worse prognosis.24
Some limitations to this study deserve to be mentioned.
Although this study involved a consecutive cohort, the data
was obtained retrospectively. This may cause difficulty in
obtaining accurate data. However, we had little missing data
in the variables obtained, likely due to a fairly consistent
hospital system with electronic hospital files available for
the majority of the study period. A larger study population
may have revealed associations not seen in this study; how-
ever, most of the results are in line with the recent national data
from Denmark,5 and as such, this study from the greater
Stavanger area should have a wide external validity.
Conclusion
The combination of age, active cancer, hyperbilirubinaemia,
hypoalbuminaemia, elevated creatinine and delay from perfo-
ration to surgery of >24 h predicted mortality best.
The new PULP score and the ASA score predicted mortal-
ity equally well and better than the Boey score, but none of
them were optimal. Hypoalbuminaemia was the strongest
single predictor of mortality and may be included for im-
proved risk estimation.
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